p53 regulates the expression of human angiotensin II AT(2) receptor interacting protein (ATIP1) gene

Zujian Chen1, Xiqiang Liu, Cheng Wang

  • 1Center for Molecular Biology of Oral Diseases, College of Dentistry, University of Illinois at Chicago, Chicago, IL, USA.

Oncology Letters
|October 26, 2011
PubMed

Insights

The tumor suppressor Angiotensin II AT(2) receptor interacting protein 1 (ATIP1) is regulated by the p53 protein. p53 directly binds to the ATIP1 promoter, influencing its expression and impacting cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Angiotensin II AT(2) receptor interacting protein 1 (ATIP1) is recognized as a tumor suppressor.
  • Understanding the regulatory mechanisms of ATIP1 is crucial for cancer research.

Purpose of the Study:

  • To investigate the transcriptional regulation of the human ATIP1 gene.
  • To determine the role of the p53 protein in controlling ATIP1 expression.

Main Methods:

  • Cloning and promoter activity assay of the 5' flanking region of the ATIP1 gene.
  • Identification of p53 binding sites within the ATIP1 promoter.
  • Reporter gene assays and chromatin-immunoprecipitation to confirm p53-ATIP1 promoter interaction.
  • p53 knockdown and mutation studies to assess functional impact.

Main Results:

  • A 2.2 kb fragment of the ATIP1 5' flanking region demonstrated promoter activity.
  • Two putative p53 binding sites were identified in the minimal ATIP1 promoter.
  • p53 significantly enhanced ATIP1 expression, while p53 knockdown reduced it.
  • Direct binding of p53 to the ATIP1 promoter was confirmed, and mutation of these sites abolished p53's regulatory effect.

Conclusions:

  • The ATIP1 gene is transcriptionally regulated by the p53 protein.
  • p53 plays a significant role in modulating ATIP1 expression.
  • ATIP1, regulated by p53, may be important in cancer initiation and progression.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...